-
公开(公告)号:WO2016172496A8
公开(公告)日:2016-12-22
申请号:PCT/US2016028864
申请日:2016-04-22
发明人: ALBRECHT BRIAN K , AUDIA JAMES EDMUND , CÔTÉ ALEXANDRE , DUPLESSIS MARTIN , GEHLING VICTOR S , HARMANGE JEAN-CHRISTOPHE , VASWANI RISHI G
IPC分类号: C07D309/20 , A61K31/4465 , A61P35/00 , C07C211/22 , C07C211/35 , C07C215/44 , C07D205/12 , C07D207/32 , C07D211/22 , C07D211/26 , C07D211/36 , C07D213/64 , C07D215/44 , C07D239/30 , C07D263/32 , C07D305/06 , C07D317/28 , C07D401/04 , C07D401/06 , C07D403/04 , C07D403/06 , C07D403/10 , C07D405/04 , C07D417/06
CPC分类号: C07D211/26 , C07B2200/07 , C07C211/09 , C07C211/36 , C07C211/40 , C07C215/14 , C07C215/44 , C07C217/08 , C07C229/10 , C07C229/38 , C07C229/46 , C07C233/41 , C07C237/06 , C07C255/24 , C07C255/58 , C07C2601/02 , C07C2601/04 , C07C2601/14 , C07C2602/44 , C07D205/12 , C07D207/32 , C07D211/22 , C07D211/36 , C07D213/64 , C07D215/44 , C07D239/30 , C07D263/32 , C07D305/06 , C07D309/20 , C07D317/28 , C07D401/04 , C07D401/06 , C07D403/04 , C07D403/06 , C07D403/10 , C07D405/04 , C07D417/06
摘要: Provided are novel compounds of Formula (I) and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions, associated with LSDl. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with LSDl.
摘要翻译: 提供式(I)的新化合物及其药学上可接受的盐,其可用于治疗与LSD1相关的各种疾病,病症或病症。 还提供了包含式(I)的新化合物,其药学上可接受的盐及其用于治疗与LSD1相关的一种或多种疾病,病症或病症的方法的药物组合物。
-
公开(公告)号:WO2012174487A8
公开(公告)日:2014-01-16
申请号:PCT/US2012042825
申请日:2012-06-15
申请人: CONSTELLATION PHARMACEUTICALS INC , ALBRECHT BRIAN K , HARMANGE JEAN-CHRISTOPHE , COTE ALEXANDRE , TAYLOR ALEXANDER M
IPC分类号: C07D487/04 , A61K31/5025 , A61P35/00 , C07D403/04
CPC分类号: C07D487/04 , A61K31/5025
摘要: The present invention relates to compounds useful as inhibitors of bromodomain-containing proteins. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of various disorders.
摘要翻译: 本发明涉及可用作含溴结构域蛋白质的抑制剂的化合物。 本发明还提供包含本发明化合物的药学上可接受的组合物和使用所述组合物治疗各种疾病的方法。
-
公开(公告)号:WO2012174487A3
公开(公告)日:2013-04-25
申请号:PCT/US2012042825
申请日:2012-06-15
申请人: CONSTELLATION PHARMACEUTICALS INC , ALBRECHT BRIAN K , HARMANGE JEAN-CHRISTOPHE , COTE ALEXANDRE , TAYLOR ALEXANDRE M
IPC分类号: C07D487/04 , A61K31/5025 , A61P35/00 , C07D403/04
CPC分类号: C07D487/04 , A61K31/5025
摘要: The present invention relates to compounds useful as inhibitors of bromodomain-containing proteins. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of various disorders.
摘要翻译: 本发明涉及可用作含溴结构域蛋白质的抑制剂的化合物。 本发明还提供包含本发明化合物的药学上可接受的组合物和使用所述组合物治疗各种疾病的方法。
-
4.INDOLE DERIVATIVES AS MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF 审中-公开
标题翻译: 作为甲基修饰酶的调节剂的吲哚衍生物,其组合物及其用途公开(公告)号:WO2015023915A1
公开(公告)日:2015-02-19
申请号:PCT/US2014051201
申请日:2014-08-15
发明人: ALBRECHT BRIAN K , AUDIA JAMES EDMUND , DAKIN LES A , DUPLESSIS MARTIN , GEHLING VICTOR S , HARMANGE JEAN-CHRISTOPHE , NASVESCHUK CHRISTOPHER G , VASWANI RISHI G
IPC分类号: C07D401/12 , A61K31/4439 , A61P35/00
CPC分类号: C07D401/14 , C07D401/12 , C07D405/14 , C07D413/14
摘要: Agents of formulas (l)/(ll)/(lll) for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.
摘要翻译: 本文提供了用于调节甲基修饰酶的式(I)/(II)/(III)的试剂,其组合物和用途。
-
5.MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF 审中-公开
标题翻译: 甲基化改性酶的调节剂,组合物及其用途公开(公告)号:WO2013075083A8
公开(公告)日:2014-05-30
申请号:PCT/US2012065796
申请日:2012-11-19
发明人: ALBRECHT BRIAN K , AUDIA JAMES EDMUND , COOK ANDREW , GAGNON ALEXANDRE , HARMANGE JEAN-CHRISTOPHE , NASVESCHUK CHRISTOPHER G
IPC分类号: A61K31/4412
CPC分类号: C07D213/64 , C07D221/18 , C07D401/12 , C07D405/12 , C07D413/12
摘要: Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.
摘要翻译: 本文提供了用于调节甲基修饰酶的试剂,组合物和用途。
-
公开(公告)号:WO2012075383A2
公开(公告)日:2012-06-07
申请号:PCT/US2011063046
申请日:2011-12-02
申请人: CONSTELLATION PHARMACEUTICALS INC , ALBRECHT BRIAN K , AUDIA JAMES EDMUND , COTE ALEXANDRE , GEHLING VICTOR S , HARMANGE JEAN-CHRISTOPHE , HEWITT MICHAEL C , LEBLANC YVES , NAVESCHUK CHRISTOPHER G , TAYLOR ALEXANDER M , VASWANI RISHI G
发明人: ALBRECHT BRIAN K , AUDIA JAMES EDMUND , COTE ALEXANDRE , GEHLING VICTOR S , HARMANGE JEAN-CHRISTOPHE , HEWITT MICHAEL C , LEBLANC YVES , NAVESCHUK CHRISTOPHER G , TAYLOR ALEXANDER M , VASWANI RISHI G
IPC分类号: C07D498/04 , A61K31/424 , A61K31/55 , A61P35/00 , C07D498/14
CPC分类号: A61K31/424 , A61K31/55 , C07D498/04 , C07D498/14
摘要: The present invention relates to compounds useful as inhibitors of bromodomain-containing proteins. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of various disorders.
摘要翻译: 本发明涉及用作含溴结构域蛋白抑制剂的化合物。 本发明还提供了包含本发明化合物的药学上可接受的组合物以及使用所述组合物治疗各种疾病的方法。
-
公开(公告)号:WO2013120104A3
公开(公告)日:2014-03-06
申请号:PCT/US2013025639
申请日:2013-02-11
发明人: ALBRECHT BRIAN K , AUDIA JAMES EDMUND , COOK ANDREW S , DAKIN LES A , DUPLESSIS MARTIN , GEHLING VICTOR S , HARMANGE JEAN-CHRISTOPHE , NASVESCHUK CHRISTOPHER G , VASWANI RISHI G
IPC分类号: A61K31/50 , A01N43/58 , C07D401/00
CPC分类号: A61K31/4545 , C07D401/12 , C07D401/14 , C07D405/14 , C07D409/06 , C07D417/04 , C07D417/14 , C07D471/04 , C07D487/04
摘要: Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.
-
公开(公告)号:WO2012151512A3
公开(公告)日:2013-03-28
申请号:PCT/US2012036569
申请日:2012-05-04
申请人: CONSTELLATION PHARMACEUTICALS INC , ALBRECHT BRIAN K , GEHLING VICTOR S , HEWITT MICHAEL C , TAYLOR ALEXANDER M , HARMANGE JEAN-CHRISTOPHE
发明人: ALBRECHT BRIAN K , GEHLING VICTOR S , HEWITT MICHAEL C , TAYLOR ALEXANDER M , HARMANGE JEAN-CHRISTOPHE
IPC分类号: C07D487/04 , A61K31/5517 , A61P35/00 , C07D401/04
CPC分类号: C07D487/04
摘要: The present invention relates to compounds useful as inhibitors of bromodomain-containing proteins. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of various disorders.
-
-
-
-
-
-
-